On Tuesday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.89 which represents a decrease of $-0.11 or -1.83% from the prior close of $6. The stock opened at $5.97 and ...
On Friday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.7 which represents a decrease of $-0.05 or -0.87% from the prior close of $5.75. The stock opened at $5.78 and ...
Indeed, shares of RXRX stock are rocketing more than 10% higher today on some rather intriguing catalysts. Yesterday, the company made a big announcement at the J.P. Morgan Healthcare Conference.
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) President and Chief Operating Officer, Tina Marriott, has executed a sale of company shares, according to a recent Form 4 filing with ...
In the latest market close, Recursion Pharmaceuticals (RXRX) reached $6.67, with a -0.74% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.76%.
Short interest and days to cover can be used to indicate market sentiment and gauge the stock market in an investor’s analysis. Please note: If days to cover is between 0 and 1, it is rounded up ...